- Home
- ANIK vs BWAY Comparison
ANIK vs BWAY Comparison
Compare ANIK & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- BWAY
- Stock Information
- Founded
- ANIK 1983
- BWAY 2003
- Country
- ANIK United States
- BWAY Israel
- Employees
- ANIK N/A
- BWAY N/A
- Industry
- ANIK Medical/Dental Instruments
- BWAY Medical/Dental Instruments
- Sector
- ANIK Health Care
- BWAY Health Care
- Exchange
- ANIK Nasdaq
- BWAY Nasdaq
- Market Cap
- ANIK 243.4M
- BWAY 207.4M
- IPO Year
- ANIK 1993
- BWAY 2019
- Fundamental
- Price
- ANIK $15.07
- BWAY $9.47
- Analyst Decision
- ANIK Buy
- BWAY Strong Buy
- Analyst Count
- ANIK 2
- BWAY 3
- Target Price
- ANIK $22.00
- BWAY $13.17
- AVG Volume (30 Days)
- ANIK 88.8K
- BWAY 54.4K
- Earning Date
- ANIK 03-12-2025
- BWAY 03-11-2025
- Dividend Yield
- ANIK N/A
- BWAY N/A
- EPS Growth
- ANIK N/A
- BWAY N/A
- EPS
- ANIK N/A
- BWAY 0.09
- Revenue
- ANIK $119,907,000.00
- BWAY $41,016,000.00
- Revenue This Year
- ANIK N/A
- BWAY $349.63
- Revenue Next Year
- ANIK $8.50
- BWAY $27.16
- P/E Ratio
- ANIK N/A
- BWAY $59.48
- Revenue Growth
- ANIK N/A
- BWAY 29.04
- 52 Week Low
- ANIK $14.79
- BWAY $4.61
- 52 Week High
- ANIK $29.12
- BWAY $11.79
- Technical
- Relative Strength Index (RSI)
- ANIK 36.11
- BWAY 42.67
- Support Level
- ANIK $14.99
- BWAY $9.36
- Resistance Level
- ANIK $15.79
- BWAY $9.95
- Average True Range (ATR)
- ANIK 0.73
- BWAY 0.44
- MACD
- ANIK -0.07
- BWAY -0.04
- Stochastic Oscillator
- ANIK 15.32
- BWAY 32.70
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.